The stable inhibitory functions of Treg are essential for controlling inflammation and preventing autoimmune disorders, infectious diseases, and cancers A reduction in the expression of Foxp3 or the frequency of Tregs has been observed in various diseases, including RA, type 1 diabetes mellitus, and multiple sclerosis [45–47]. This evidence concerns the gene FOXP3 and cancer.